Ipsen's Latest Consumer Health Play: Growth Or Attracting Suitors?
This article was originally published in The Pink Sheet
Executive Summary
Less than a month after investing in Italian nutritional supplement maker Akkadeas Pharma, Ipsen acquires five Sanofi OTC drug brands marketed in Europe, including Prontalgine analgesics available in France.